Publisher Correction to: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis.
| Publicado en: | International Journal of Clinical Pharmacy Vol. 44; no. 6; pp. 1572 - 1573 |
|---|---|
| Autores principales: | , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Dec2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=160563734&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 160563734 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 22107703 BGX3 jtl: International Journal of Clinical Pharmacy issn: 22107703 maglogo: N pubinfo: dt: Dec2022 vid: 44 iid: 6 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 160563734 159717623 10.1007/s11096-022-01479-4 160563734 ppf: 1572 ppct: 1 formats: tig: atl: Publisher Correction to: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis. aug: au: Cui, Yuying Guo, Yingxue affil: School of Clinical Medicine, Jiamusi University, 154007, Jiamusi, China sug: pubtype: Academic Journal doctype: Journal Article ougenre: Unknown ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|